Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Guichan Liao, Ziying Liu, Muye Xia, Hongjie Chen, Houji Wu, Bing Li, Tao Yu, Shaohang Cai, Xiaoyong Zhang & Jie Peng. (2022) Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued. Infection and Drug Resistance 15, pages 2347-2357.
Read now
Read now
Anna Pawłowska, Dorota Suszczyk, Rafał Tarkowski, Roman Paduch, Jan Kotarski & Iwona Wertel. (2020) Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients. Cancer Management and Research 12, pages 9691-9709.
Read now
Read now
Kristian Aarslev, Anders Dige, Stinne R. Greisen, Martin Kreutzfeldt, Niels Jessen, Hendrik Vilstrup, Bent Deleuran & Henning Grønbæk. (2017) Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis. Scandinavian Journal of Gastroenterology 52:1, pages 93-99.
Read now
Read now
Articles from other publishers (65)
Junko Tanizaki, Hiroaki Kuroda, Toshihide Yokoyama, Makoto Takahama, Hiroyasu Shoda, Atsushi Nakamura, Yoshitaka Kitamura, Nobuaki Mamesaya, Yoshihisa Kadota, Kenji Sawa, Kyoichi Okishio, Morihito Okada, Chihiro Suminaka, Kenta Noda, Kazuko Sakai, Yasutaka Chiba, Kazuto Nishio, Kenji Chamoto, Tasuku Honjo, Nobuyuki Yamamoto, Kazuhiko Nakagawa & Hidetoshi Hayashi. (2023) Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy. JTO Clinical and Research Reports 4:12, pages 100590.
Crossref
Crossref
Mussarat Wahid, Benjamart Pratoomthai, Isioma U. Egbuniwe, Hannah R. Evans, Roya Babaei-Jadidi, Jason O. Amartey, Viola Erdelyi, Kiren Yacqub-Usman, Andrew M. Jackson, Jonathan C. Morris, Poulam M. Patel & David O. Bates. (2023) Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion. Cancer Immunology, Immunotherapy 72:12, pages 4001-4014.
Crossref
Crossref
Yuxiang Du & Bo Yan. (2023) Ocular immune privilege and retinal pigment epithelial cells. Journal of Leukocyte Biology 113:3, pages 288-304.
Crossref
Crossref
Anne Sofie Sørensen, Morten Nørgaard Andersen, Kristian Juul-Madsen, Amalie Dyrelund Broksø, Cæcilie Skejø, Henrik Schmidt, Thomas Vorup-Jensen & Tue Wenzel Kragstrup. (2022) Tumor necrosis factor alpha neutralization attenuates immune checkpoint inhibitor-induced activation of intermediate monocytes in synovial fluid mononuclear cells from patients with inflammatory arthritis. Arthritis Research & Therapy 24:1.
Crossref
Crossref
Matthew J. Loza, Sunil Nagpal, Suzanne Cole, Renee M. Laird, Ashley Alcala, Navin L. Rao, Mark S. Riddle & Chad K. Porter. (2022) Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel. Arthritis & Rheumatology 74:11, pages 1766-1775.
Crossref
Crossref
Yong Gu, Ying Y. Tang, Jian X. Wan, Jian Y. Zou, Chuan G. Lu, Hao S. Zhu, Si Y. Sheng, Yan F. Wang, Hai Ch. Liu, Jia Yang & Hai Hong. (2022) Sex difference in the expression of PD-1 of non-small cell lung cancer. Frontiers in Immunology 13.
Crossref
Crossref
Jian Lu, Jing Wu, Lingxiang Mao, Huaxi Xu & Shengjun Wang. (2022) Revisiting PD-1/PD-L pathway in T and B cell response: Beyond immunosuppression. Cytokine & Growth Factor Reviews 67, pages 58-65.
Crossref
Crossref
Mutiara Indah Sari & Syafruddin Ilyas. (2022) The Expression Levels and Concentrations of PD-1 and PD-L1 Proteins in Septic Patients: A Systematic Review. Diagnostics 12:8, pages 2004.
Crossref
Crossref
Stinne R. Greisen, Maithri Aspari & Bent Deleuran. (2022) Co-Inhibitory Molecules – Their Role in Health and Autoimmunity; Highlighted by Immune Related Adverse Events. Frontiers in Immunology 13.
Crossref
Crossref
Annette Affolter, Johann Kern, Karen Bieback, Claudia Scherl, Nicole Rotter & Anne Lammert. (2022) Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review). International Journal of Oncology 61:1.
Crossref
Crossref
Iñigo Les, Inés Pérez-Francisco, María Cabero, Cristina Sánchez, María Hidalgo, Lucía Teijeira, Virginia Arrazubi, Severina Domínguez, Pilar Anaut, Saioa Eguiluz, Iñaki Elejalde, Alberto Herrera & Mireia Martínez. (2022) Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study. Frontiers in Pharmacology 13.
Crossref
Crossref
Amir Tajbakhsh, Seyed Mohammad Gheibihayat, Ramezan Ali Taheri, Mahdi Fasihi-Ramandi, Abolfazl Nesaei Bajestani & Abolfazl Taheri. (2022) Potential diagnostic and prognostic of efferocytosis-related unwanted soluble receptors/ligands as new non-invasive biomarkers in disorders: a review. Molecular Biology Reports 49:6, pages 5133-5152.
Crossref
Crossref
Stinne R. Greisen, Tue W. Kragstrup, Jesper Skovhus Thomsen, Kim Hørslev-Pedersen, Merete Lund Hetland, Kristian Stengaard-Pedersen, Mikkel Østergaard, Lykke Ørnbjerg, Peter Junker, Arlene H. Sharpe, Gordon J. Freeman, Malene Hvid, Søren K. Moestrup, Ellen Margrethe Hauge & Bent Deleuran. (2022) The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings. Frontiers in Immunology 13.
Crossref
Crossref
Adam Mor & Marianne Strazza. (2022) Bridging the Gap: Connecting the Mechanisms of Immune-Related Adverse Events and Autoimmunity Through PD-1. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Jin Wang, Yawei Tang, Chunli Wu, Weiping Li, Bing Wang, Minli Jin, Chunlai Yin & Xia Li. (2021)
PD‐1
+
CXCR5
‐
CD4
+
T cells are correlated with the severity of lung adenocarcinoma malignant processes
. Scandinavian Journal of Immunology 95:1.
Crossref
Crossref
Ryotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, Daisuke Takayanagi, Tsubasa Goshima, Rie Onoue, Kazuyuki Hamada, Yutaro Kubota, Atsushi Horiike, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Junji Tsurutani, Kiyoshi Yoshimura, Mayumi Tsuji, Yuji Kiuchi, Shinichi Kobayashi, Takuya Tsunoda & Satoshi Wada. (2021) Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies. Biomedicines 9:12, pages 1929.
Crossref
Crossref
Yumei Zhong, Deli Lai, Linlin Zhang, Wenting Lu, Yanan Shang & Haiyan Zhou. (2021) The Effects of Moxibustion on PD-1/PD-L1-Related Molecular Expression and Inflammatory Cytokine Levels in RA Rats. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-10.
Crossref
Crossref
Li Xu, Lichun Jiang, Liuyan Nie, Songzhao Zhang, Lei Liu, Yan Du & Jing Xue. (2021) Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis. BMC Immunology 22:1.
Crossref
Crossref
Erdal Sag, Selcan Demir, Maithri Aspari, Morten Aagaard Nielsen, Cæcilie Skejø, Malene Hvid, Egemen Turhan, Yelda Bilginer, Stinne Greisen, Seza Ozen & Bent Deleuran. (2021) Juvenile idiopathic arthritis: lymphocyte activation gene-3 is a central immune receptor in children with oligoarticular subtypes. Pediatric Research 90:4, pages 744-751.
Crossref
Crossref
Sara Youssry, Amina Hussein & Mai Moaaz. (2021) The immunoregulatory axis (programmed death‐1/programmed death ligand‐1) on CD4+ T cells in lupus nephritis: association with vitamin D and chemokine C‐X‐C motif ligand 12. Microbiology and Immunology 65:9, pages 392-399.
Crossref
Crossref
Muhammad Khan, Sumbal Arooj & Hua Wang. (2021) Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Julie B. Mortensen, Ida Monrad, Marie B. Enemark, Maja Ludvigsen, Peter Kamper, Mette Bjerre & Francesco d'Amore. (2021) Soluble programmed cell death protein 1 (sPD‐1) and the soluble programmed cell death ligands 1 and 2 (sPD‐L1 and sPD‐L2) in lymphoid malignancies. European Journal of Haematology 107:1, pages 81-91.
Crossref
Crossref
Christian Bailly, Xavier Thuru & Bruno Quesnel. (2021) Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases. Cancers 13:12, pages 3034.
Crossref
Crossref
Yujia Zhai, Reza Moosavi & Mingnan Chen. (2021) Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases. Frontiers in Immunology 12.
Crossref
Crossref
Stinne Ravn Greisen & Bent Deleuran. (2021) Checkpoint Molecules in Rheumatology—or the Benefits of Being Exhausted. Current Rheumatology Reports 23:4.
Crossref
Crossref
Xingxing Yu, Yu Pan, Qinglin Fei, Xianchao Lin, Zhijiang Chen & Heguang Huang. (2021) Serum soluble PD‐1 plays a role in predicting infection complications in patients with acute pancreatitis. Immunity, Inflammation and Disease 9:1, pages 310-318.
Crossref
Crossref
Heli Vajavaara, Julie Bondgaard Mortensen, Suvi-Katri Leivonen, Ida Monrad Hansen, Maja Ludvigsen, Harald Holte, Judit Jørgensen, Mette Bjerre, Francesco d’Amore & Sirpa Leppä. (2021) Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma. Cancers 13:3, pages 398.
Crossref
Crossref
Shuo Zhang, Li Wang, Mengtao Li, Fengchun Zhang & Xiaofeng Zeng. (2021) The PD-1/PD-L pathway in rheumatic diseases. Journal of the Formosan Medical Association 120:1, pages 48-59.
Crossref
Crossref
Muhammad Khan, Zhihong Zhao, Sumbal Arooj, Yuxiang Fu & Guixiang Liao. (2020) Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy. Frontiers in Immunology 11.
Crossref
Crossref
Yanyan HuangChuying PanYing LiuShudian LinYuwei ZhanYan ZhangFeng Zhan. (2020) Immune Function and Mechanism of Costimulating Molecules PD-1 and OX40 in Rheumatoid Arthritis. Journal of Interferon & Cytokine Research 40:11, pages 530-539.
Crossref
Crossref
Xiuzhen Zhao, Tao Jin, Chao Zheng, Di Ma & Ying Zhang. (2020) Imbalance of Circulating Tfh/Tfr Cells in Patients With Parkinson's Disease. Frontiers in Neurology 11.
Crossref
Crossref
Yan Du, Liuyan Nie, Li Xu, Xinyu Wu, Songzhao Zhang & Jing Xue. (2020) Serum levels of soluble programmed death‐1 (sPD‐1) and soluble programmed death ligand 1(sPD‐L1) in systemic lupus erythematosus: Association with activity and severity. Scandinavian Journal of Immunology 92:1.
Crossref
Crossref
Albin Björk, Gudny Ella Thorlacius, Johannes Mofors, Elina Richardsdotter Andersson, Margarita Ivanchenko, Joanna Tingström, Tojo James, Karl A Brokstad, Rebecca J Cox, Roland Jonsson, Marika Kvarnström & Marie Wahren-Herlenius. (2020) Viral antigens elicit augmented immune responses in primary Sjögren’s syndrome. Rheumatology 59:7, pages 1651-1661.
Crossref
Crossref
Shinya Hirahara, Yasuhiro Katsumata, Hidenaga Kawasumi, Yashushi Kawaguchi & Masayoshi Harigai. (2020) Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity. Lupus 29:7, pages 686-696.
Crossref
Crossref
Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, Elizabeth Fabre, Marie Wislez, Marco Alifano, Karen Leroy, Pascaline Boudou-Rouquette, Camille Tlemsani, Nihel Khoudour, Jennifer Arrondeau, Audrey Thomas-Schoemann, Hélène Blons, Audrey Mansuet-Lupo, Diane Damotte, Michel Vidal, François Goldwasser, Jérôme Alexandre & Benoit Blanchet. (2020) Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study. Cancers 12:2, pages 473.
Crossref
Crossref
Albin Björk, Elina Richardsdotter Andersson, Juliana Imgenberg-Kreuz, Gudny Ella Thorlacius, Johannes Mofors, Ann-Christine Syvänen, Marika Kvarnström, Gunnel Nordmark & Marie Wahren-Herlenius. (2020) Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjögren’s syndrome. RMD Open 6:1, pages e000995.
Crossref
Crossref
Stinne R. Greisen, Tue W. Kragstrup, Jesper Skovhus Thomsen, Aida Solhøj Hansen, Akilan Krishnamurthy, Kim Hørslev-Petersen, Merete Lund Hetland, Kristian Stengaard-Pedersen, Mikkel Østergaard, Lykke Midtbøll Ørnbjerg, Peter Junker, Arlene H. Sharpe, Gordon J. Freeman, Lakshmanan Annamalai, Malene Hvid, Søren K. Moestrup, Ellen-Margrethe Hauge, Anca Irinel Catrina & Bent Deleuran. (2020) Programmed death ligand 2 – A link between inflammation and bone loss in rheumatoid arthritis. Journal of Translational Autoimmunity 3, pages 100028.
Crossref
Crossref
Xintong Hu, Yue Gu, Dan Li, Songchen Zhao, Shucheng Hua & Yanfang Jiang. (2019)
Analyzing the percentage of different
PD
‐1
+
T cell subsets in peripheral blood and bronchoalveolar lavage fluid of small cell lung cancer patients: A prospective study
. Clinical and Experimental Pharmacology and Physiology 46:12, pages 1074-1083.
Crossref
Crossref
Taher Abu Hejleh, Muhammad Furqan, Zuhair Ballas & Gerald Clamon. (2019) The clinical significance of soluble PD-1 and PD-L1 in lung cancer. Critical Reviews in Oncology/Hematology 143, pages 148-152.
Crossref
Crossref
Ji-Soo KwonJoung Ha ParkJi Yeun KimHye Hee ChaMin-Jae KimYong Pil ChongSang-Oh LeeSang-Ho ChoiYang Soo KimJun Hee WooYong Seo Koo, Sang-Beom Jeon, Sang-Ahm Lee & Sung-Han Kim. (2019) Diagnostic Usefulness of Cytokine and Chemokine Levels in the Cerebrospinal Fluid of Patients with Suspected Tuberculous Meningitis. The American Journal of Tropical Medicine and Hygiene 101:2, pages 343-349.
Crossref
Crossref
Yongzhen Zhao, Yumei Jia, Chunsheng Li, Rui Shao & Yingying Fang. (2019) Predictive Value of Soluble Programmed Death-1 for Severe Sepsis and Septic Shock During the First Week in an Intensive Care Unit. Shock 51:3, pages 289-297.
Crossref
Crossref
Rituparna Chakrabarti, Bhavya Kapse & Gayatri Mukherjee. (2019) Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis. CANCER REPORTS, pages e1160.
Crossref
Crossref
Jianjun Jin, Jiming Si, Yuanhua Liu, Huanqin Wang, Ran Ni & Jing Wang. (2018) Elevated serum soluble programmed cell death ligand 1 concentration as a potential marker for poor prognosis in small cell lung cancer patients with chemotherapy. Respiratory Research 19:1.
Crossref
Crossref
Kotaro Matsuda, Hiroaki Miyoshi, Koji Hiraoka, Tetsuya Hamada, Shiro Yoshida, Yukinao Ishibashi, Toshiaki Haraguchi, Naoto Shiba & Koichi Ohshima. (2018) Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis. Clinical and Experimental Medicine 18:4, pages 487-494.
Crossref
Crossref
Lan Dai, Linyan He, Zhaoyue Wang, Xia Bai, Yang He, Lijuan Cao, Mingqing Zhu & Changgeng Ruan. (2018) Altered circulating T follicular helper cells in patients with chronic immune thrombocytopenia. Experimental and Therapeutic Medicine.
Crossref
Crossref
Yanxia Guo, Alice M. Walsh, Mary Canavan, Mihir D. Wechalekar, Suzanne Cole, Xuefeng Yin, Brittney Scott, Mathew Loza, Carl Orr, Trudy McGarry, Michele Bombardieri, Frances Humby, Susanna M. Proudman, Costantino Pitzalis, Malcolm D. Smith, Joshua R. Friedman, Ian Anderson, Loui Madakamutil, Douglas J. Veale, Ursula Fearon & Sunil Nagpal. (2018) Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression. PLOS ONE 13:2, pages e0192704.
Crossref
Crossref
Tao Li, Yunpeng Shi, Weixia Sun, Haifeng Wang, Quan Wang & Yanfang Jiang. (2018) Increased PD-1+CD154+ Tfh cells are possibly the most important functional subset of PD-1+ T follicular helper cells in adult patients with minimal change disease. Molecular Immunology 94, pages 98-106.
Crossref
Crossref
Wei Wei, Bin Xu, Yan Wang, Chen Wu, Jingting Jiang & Changping Wu. (2018) Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors. Medicine 97:3, pages e9617.
Crossref
Crossref
Yongzhen Zhao, Yumei Jia, Chunsheng Li, Yingying Fang & Rui Shao. (2018) The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department. The American Journal of Emergency Medicine 36:1, pages 43-48.
Crossref
Crossref
Takemichi Fukasawa, Ayumi Yoshizaki, Satoshi Ebata, Kouki Nakamura, Ryosuke Saigusa, Syunsuke Miura, Takashi Yamashita, Megumi Hirabayashi, Yohei Ichimura, Takashi Taniguchi, Yoshihide Asano, Hisashi Shimizu, Yutaka Kazoe, Kazuma Mawatari, Takehiko Kitamori & Shinichi Sato. (2017) Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis. Arthritis & Rheumatology 69:9, pages 1879-1890.
Crossref
Crossref
Sabina Sandigursky, Gregg J. Silverman & Adam Mor. (2017) Targeting the programmed cell death-1 pathway in rheumatoid arthritis. Autoimmunity Reviews 16:8, pages 767-773.
Crossref
Crossref
Stinne R. Greisen, Yan Yan, Aida S. Hansen, Morten T. Venø, Jens R. Nyengaard, Søren K. Moestrup, Malene Hvid, Gordon J. Freeman, Jørgen Kjems & Bent Deleuran. (2017) Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis. Frontiers in Immunology 8.
Crossref
Crossref
D Bommarito, C Hall, L S Taams & V M Corrigall. (2017) Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1. Clinical and Experimental Immunology 188:3, pages 455-466.
Crossref
Crossref
Mia Bendix, Stinne Greisen, Anders Dige, Christian L. Hvas, Nina Bak, Søren P. Jørgensen, Jens F. Dahlerup, Bent Deleuran & Jørgen Agnholt. (2017) Vitamin D increases programmed death receptor-1 expression in Crohn’s disease. Oncotarget 8:15, pages 24177-24186.
Crossref
Crossref
Yusuke Okuma, Yukio Hosomi, Yoshiro Nakahara, Kageaki Watanabe, Yukiko Sagawa & Sadamu Homma. (2017) High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer. Lung Cancer 104, pages 1-6.
Crossref
Crossref
Anna Lange, Jonas Sundén-Cullberg, Anders Magnuson & Olof Hultgren. (2017) Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality. PLOS ONE 12:1, pages e0169176.
Crossref
Crossref
Chun-Feng Ren, Ya-Xin Zhao, Chun-Feng Hou, Luan Luan, Guo-Qing Duan, Shu-Jie Li & Jian-Hong Zhao. (2017) Expression of soluble programmed death-1 protein in peripheral blood regulatory T cells and its effects on rheumatoid arthritis progression. Molecular Medicine Reports 15:1, pages 460-466.
Crossref
Crossref
Steffen Filskov Sorensen, Christina Demuth, Britta Weber, Boe Sandahl Sorensen & Peter Meldgaard. (2016) Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR -mutated non-small cell lung cancer treated with erlotinib. Lung Cancer 100, pages 77-84.
Crossref
Crossref
Koichi Yanaba, Mitsuha Hayashi, Yuki Yoshihara & Hidemi Nakagawa. (2016) Serum levels of soluble programmed death‐1 and programmed death ligand‐1 in systemic sclerosis: Association with extent of skin sclerosis. The Journal of Dermatology 43:8, pages 954-957.
Crossref
Crossref
Cuiping Liu, Juean Jiang, Li Gao, Xiaoting Wang, Xiaohan Hu, Min Wu, Jian Wu, Ting Xu, Qin Shi & Xueguang Zhang. (2015) Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways. Arthritis Research & Therapy 17:1.
Crossref
Crossref
Waleed A. Hassan, Eman A. Baraka & Nehad A. Fouad. (2015) Clinical significance of soluble programmed death-1(sPD-1) in rheumatoid arthritis patients: Relation to disease activity and functional status. The Egyptian Rheumatologist 37:4, pages 165-169.
Crossref
Crossref
Yan G. Ni, Xiling Yuan, John A. Newitt, Jon E. Peterson, Carol R. Gleason, Jonathan Haulenbeek, Rasa Santockyte, Virginie Lafont, Frank Marsilio, Robert J. Neely, Binodh DeSilva & Steven P. Piccoli. (2015) Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay. The AAPS Journal 17:4, pages 976-987.
Crossref
Crossref
Mingyuan Yang, Yuming Zou, Yushu Bai & Ming Li. (2015) The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis. Journal of Orthopaedic Science 20:1, pages 55-63.
Crossref
Crossref
Parakkal Jovvian George, Nathella Pavan Kumar, Rathinam Sridhar, Luke E. Hanna, Dina Nair, Vaithilingam V. Banurekha, Thomas B. Nutman & Subash Babu. (2014) Coincident Helminth Infection Modulates Systemic Inflammation and Immune Activation in Active Pulmonary Tuberculosis. PLoS Neglected Tropical Diseases 8:11, pages e3289.
Crossref
Crossref
Suya Dai, Ru Jia, Xiao Zhang, Qiwen Fang & Lijuan Huang. (2014) The PD-1/PD-Ls pathway and autoimmune diseases. Cellular Immunology 290:1, pages 72-79.
Crossref
Crossref